Results 191 to 200 of about 1,235,726 (352)
Low Incidence of Relapses After Vaccination in Anti‐Aquaporin‐4 Antibody‐Positive NMOSD
ABSTRACT Patients with neuromyelitis optica spectrum disorder (NMOSD) may experience increased signs and symptoms of their underlying disease when vaccinated against meningococcal disease before receiving complement component 5 inhibitor therapies. This retrospective analysis indicated an overall low relapse incidence (mean [range], 3.3% [0.7%–10.6 ...
Sean J. Pittock +4 more
wiley +1 more source
Sex Representation in US Stroke Clinical Trials: A Decade of Trends and Challenges
ABSTRACT Objective Stroke remains a major cause of disability and mortality in the US, with significant sex‐based disparities, and females remain underrepresented in stroke clinical trials. We aimed to examine sex representation in US‐based stroke clinical trials, identify trial characteristics associated with higher female enrollment (≥ 50%), and ...
Chaitali Dagli +5 more
wiley +1 more source
Differences in the product characteristics and clinical use of granulocytes for transfusion: The BEST Collaborative study. [PDF]
Cain L +28 more
europepmc +1 more source
A Study on the Interoperability Technology of Digital Identification Based on WACI Protocol with Multiparty Distributed Signature. [PDF]
Kim J, Kim P, Choi D, Lee Y.
europepmc +1 more source
Cracking the Code: Genotype–Phenotype Correlation Models in Sarcoglycanopathies
ABSTRACT Objective Sarcoglycanopathies are among the most severe limb‐girdle muscular dystrophies (LGMD), though milder presentations have been described. These diseases are primarily caused by missense variants, but the limited predictability of their effect on protein maturation, complex formation, and transport has hindered reliable genotype ...
Leonela Luce +72 more
wiley +1 more source
Hadoop in Banking: Event-Driven Performance Evaluation. [PDF]
Panda M +5 more
europepmc +1 more source
Investor demand in syndicated EFSF/ESM bond issuances. [PDF]
Hillebrand M, Mravlak M, Schwendner P.
europepmc +1 more source

